Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. Other stock markets 2026-06-26			5-day change	1st Jan Change
14.96 ^MXN	-0.86%		-0.60%	-16.38%

04-23	Genomma Lab Internacional, S.A.B. de C.V., Q1 2026 Earnings Call, Apr 23, 2026
04-23	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	14,590	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-16.5%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	18,452	18,054	16,923
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-17.04%	-2.16%	-6.26%
P/E	14.9x	12x	13.1x	11.7x	11.1x	6.82x	6.74x	5.4x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	1.03x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.2x	6.17x	0.2x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.8x	0.76x	0.7x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	1.01x	0.94x	0.81x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.31x	4.03x	3.45x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.7x	4.4x	3.77x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	8.29x	9.35x	7.54x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	12.1%	10.7%	13.3%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8013	1.098	1.5
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.36%	7.34%	10%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.195	2.219	2.77
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	36.5%	49.5%	54.2%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,323	19,238	20,830
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,280	4,485	4,903
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,923	4,105	4,493
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,137	2,251	2,646
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	3,862	3,464	2,334
Reference price ²	21.48	16.94	14.16	25.13	17.89	14.96	14.96	14.96
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,253	-	-
Announcement Date	2/23/22	2/22/23	2/21/24	2/26/25	2/25/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	6.82x	1.01x	4.31x	5.36%	836M
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	15.64x	5.95x	15.32x	2.72%	361.69B
Weighted average by Cap.	24.44x	7.94x	18.31x	1.97%